EGFR and gastric cancer: and found to exert an antineoplastic effect in gastric cancer cells MKN-45 by inducing apoptosis and cell cycle arrest [99] and in AGS cells by suppressing insulin-like growth factor receptor (IGFR), epidermal growth factor receptor (EGFR) expression and blocking PI3K/Akt/mTOR pathways [100, 101].